Diploma PLC reported revenue results for the first quarter ended December 31, 2022. For the quarter, the company reported Organic revenue growth 10%: broad-based momentum in Controls, sustained strong growth at Seals and Life Sciences on track for sustainable growth as surgical procedures continue to recover. Reported revenue growth 30%: 11% contribution from high quality acquisitions and a 9% foreign exchange benefit.